Acadia Pharmaceuticals
Acadia cares is our way of showing how we support the community of patients that we serve with innovative therapies today and beyond.
Acadia pharmaceuticals. Annual report corporate presentation. Pimavanserin for patients with parkinson s disease psychosis. Acadia pharmaceuticals to present at the 38th annual j p. View real time stock prices and stock quotes for a full financial overview.
Nuplazid a drug developed by acadia in the late 1990 s was designed to stimulate a subset of the brain s serotonin receptors or the proteins that govern memory cognition and learning. Stock news by marketwatch. Acadia pharmaceuticals track record of success and strong pipeline offers an attractive long term opportunity for investors especially at a depressed price. June 15 2020 acadia pharmaceuticals submits supplemental new drug application to u s.
Is a biopharmaceutical company headquartered in sorrento valley san diego california. Morgan healthcare conference on january 14 2020. Acadia pharmaceuticals s first quarter sales were driven by strong execution in marketing and commercial strategy. Acad stock quote history news and other vital information to help you with your stock trading and investing.
6 quality biotech stocks on sale now. Acad complete acadia pharmaceuticals inc. Eastern time san diego business wire apr. Nasdaq acad is not the least popular stock in this group but hedge fund interest is still below average.
The 90 1 million in revenue came from 32 volume growth year over year. Acadia to host conference call and webcast on thursday may 7 2020 at 4 30 p m. A randomized placebo controlled phase 3 trial. Acad today announced that it will report first quarter financial results on thursday may 7 2020 after the close of.
Fda for nuplazid pimavanserin for the treatment of hallucinations and delusions associated with dementia related psychosis. The lancet 383 533 540 2014. 15 2020 acadia pharmaceuticals inc.